Viatris Total Long Term Liabilities 2010-2024 | VTRS

Viatris total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
  • Viatris total long term liabilities for the quarter ending September 30, 2024 were $17.449B, a 17.08% decline year-over-year.
  • Viatris total long term liabilities for 2023 were $19.441B, a 12.44% decline from 2022.
  • Viatris total long term liabilities for 2022 were $22.204B, a 9.25% decline from 2021.
  • Viatris total long term liabilities for 2021 were $24.466B, a 12.73% decline from 2020.
Viatris Annual Total Long Term Liabilities
(Millions of US $)
2023 $19,441
2022 $22,204
2021 $24,466
2020 $28,036
2019 $13,803
2018 $15,980
2017 $16,113
2016 $18,568
2015 $8,380
2014 $7,241
2013 $9,371
2012 $6,383
2011 $5,530
2010 $6,112
2009 $5,938
Viatris Quarterly Total Long Term Liabilities
(Millions of US $)
2024-09-30 $17,449
2024-06-30 $18,101
2024-03-31 $19,570
2023-12-31 $19,441
2023-09-30 $21,043
2023-06-30 $21,328
2023-03-31 $22,254
2022-12-31 $22,204
2022-09-30 $22,959
2022-06-30 $23,639
2022-03-31 $23,376
2021-12-31 $24,466
2021-09-30 $24,825
2021-06-30 $26,645
2021-03-31 $27,586
2020-12-31 $28,036
2020-09-30 $11,420
2020-06-30 $11,438
2020-03-31 $13,655
2019-12-31 $13,803
2019-09-30 $14,945
2019-06-30 $15,354
2019-03-31 $15,857
2018-12-31 $15,980
2018-09-30 $16,207
2018-06-30 $16,200
2018-03-31 $15,621
2017-12-31 $16,113
2017-09-30 $17,543
2017-06-30 $17,504
2017-03-31 $18,092
2016-12-31 $18,568
2016-09-30 $15,156
2016-06-30 $14,730
2016-03-31 $8,410
2015-12-31 $8,380
2015-09-30 $7,817
2015-06-30 $7,856
2015-03-31 $7,743
2014-12-31 $7,241
2014-09-30 $7,294
2014-06-30 $9,649
2014-03-31 $9,514
2013-12-31 $9,371
2013-09-30 $7,107
2013-06-30 $6,940
2013-03-31 $6,715
2012-12-31 $6,383
2012-09-30 $5,913
2012-06-30 $6,239
2012-03-31 $6,044
2011-12-31 $5,530
2011-09-30 $5,249
2011-06-30 $5,604
2011-03-31 $5,568
2010-12-31 $6,112
2010-09-30 $6,142
2010-06-30 $5,989
2010-03-31 $6,004
2009-12-31 $5,938
2009-09-30 $6,107
2009-06-30 $5,909
2009-03-31 $5,907
Sector Industry Market Cap Revenue
Medical Medical Services $15.624B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $98.658B 12.24
Cencora (COR) United States $49.082B 18.10
DiDi Global (DIDIY) China $23.427B 0.00
ICON (ICLR) Ireland $17.504B 15.59
Natera (NTRA) United States $16.570B 0.00
Avantor (AVTR) United States $15.178B 22.75
Revvity (RVTY) United States $14.682B 25.50
BioMerieux (BMXMF) France $13.087B 0.00
CochLear (CHEOY) Australia $12.998B 0.00
Solventum (SOLV) United States $12.357B 0.00
Doximity (DOCS) United States $11.372B 67.31
Medpace Holdings (MEDP) United States $11.301B 31.84
Charles River Laboratories (CRL) United States $11.285B 21.81
HealthEquity (HQY) United States $8.756B 47.52
Sonic Healthcare (SKHHY) Australia $8.590B 0.00
Bausch + Lomb (BLCO) Canada $7.202B 33.53
Life Times (LTH) United States $5.139B 34.01
Sotera Health (SHC) United States $4.509B 24.12
Organon (OGN) United States $4.144B 4.18
Surgery Partners (SGRY) United States $3.996B 44.27
BrightSpring Health Services (BTSG) United States $3.489B 74.22
PACS (PACS) United States $3.347B 0.00
Alignment Healthcare (ALHC) United States $2.580B 0.00
Concentras Parent (CON) United States $2.505B 0.00
Ardent Health Partners (ARDT) United States $2.471B 0.00
Premier (PINC) United States $2.314B 11.55
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $2.016B 0.00
GoodRx Holdings (GDRX) United States $1.856B 48.90
Teladoc Health (TDOC) United States $1.689B 0.00
Progyny (PGNY) United States $1.540B 27.08
Pediatrix Medical (MD) United States $1.371B 13.41
Establishment Labs Holdings (ESTA) $1.266B 0.00
CareDx (CDNA) United States $1.252B 0.00
AMN Healthcare Services Inc (AMN) United States $1.058B 7.16
Embecta (EMBC) United States $0.910B 6.07
Agilon Health (AGL) United States $0.890B 0.00
InnovAge Holding (INNV) United States $0.809B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.723B 0.00
Auna S.A (AUNA) Luxembourg $0.516B 0.00
Sonida Senior Living (SNDA) United States $0.459B 0.00
DocGo (DCGO) United States $0.411B 15.46
Enhabit (EHAB) United States $0.403B 34.83
COMPASS Pathways (CMPS) United Kingdom $0.363B 0.00
LifeMD (LFMD) United States $0.308B 0.00
Sera Prognostics (SERA) United States $0.248B 0.00
ModivCare (MODV) United States $0.231B 12.54
Beauty Health (SKIN) United States $0.218B 0.00
Biodesix (BDSX) United States $0.205B 0.00
Nutex Health (NUTX) United States $0.152B 0.00
MultiPlan (MPLN) United States $0.137B 0.00
Ascend Wellness Holdings (AAWH) United States $0.107B 0.00
So-Young (SY) China $0.088B 21.28
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.054B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.042B 1.10
Co-Diagnostics (CODX) United States $0.038B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00